Robert R Ruffolo insider trades

Open-market stock purchases and sales by Robert R Ruffolo, Director at Elicio Therapeutics, Inc, from SEC Form 4 filings since Jun 29, 2017.

Recent trades

DateStockTradeValue
Aug 31, 2026ELTX Elicio Therapeutics, IncBought (not open market)—
Jun 3, 2026LBRX LB Pharmaceuticals IncBought (not open market)—

Companies traded

  • ELTX Elicio Therapeutics, Inc: other filings, last Aug 31, 2026
  • LBRX LB Pharmaceuticals Inc: other filings, last Jun 3, 2026
  • SGTX Sigilon Therapeutics, Inc: 1 sale, last Aug 11, 2023
  • ARDS Aridis Pharmaceuticals, Inc: other filings, last Dec 5, 2022
  • DFFN Diffusion Pharmaceuticals Inc: other filings, last Jun 14, 2018

Get free alerts when Robert R Ruffolo files a new trade →